JPMorgan, Citi Prepare for Fed’s Higher-For-Longer Approach: US Earnings Week Ahead
Views: 1836
2023-10-09 19:48
JPMorgan Chase & Co. is expected to have outperformed Citigroup Inc. and Wells Fargo & Co. in profitability

JPMorgan Chase & Co. is expected to have outperformed Citigroup Inc. and Wells Fargo & Co. in profitability when the three banks report quarterly earnings this week, though all lenders face challenges from a slow economy and high interest rates.

JPMorgan and its peers are seen bolstering loan-loss provisions further amid the lingering possibility that the US could slip into recession as early as this year. A “blowout” jobs report last week raised the likelihood the Federal Reserve will hike interest rates again, further constraining net interest income growth and highlighting the need to lower business costs.

Quarterly reports from PepsiCo Inc., Walgreens Boots Alliance Inc. and Domino’s Pizza Inc. will underscore the dwindling spending power of American consumers, who now hold less cash in hand than they did before the pandemic.

Monday: No earnings of note.

Tuesday: Pepsi (PEP US) earnings are seen rising 9.4%, slowing after two quarters of double-digit gains. Concerns that cost-conscious customers will switch to cheaper brands may be overstated, Goldman Sachs said, noting that PepsiCo enjoys a “favorable geographic footprint” over rivals. However, BI said unfavorable foreign-exchange rates likely crimped quarterly revenue growth. Pepsi, which has the capacity to take on $10 billion of debt without hurting its credit profile, could be looking to further grow its portfolio of snack brands; the company had shown interest in buying Hostess Brands, which was eventually sold to J.M. Smucker.

Wednesday: No earnings of note.

Thursday: Walgreens Boots’ (WBA US) adjusted earnings per share likely shrank 14% in the quarter, with Jefferies analysts expecting continued pressure on the profitability of its US retail pharmacy segment, the company’s largest money maker. Operational issues with VillageMD, a clinic operator in which Walgreens has a controlling stake, also likely weighed on performance. Analysts are calling Walgreen’s 2024 and 2025 guidance into question amid the drugstore chain’s recent C-suite shakeout.

Friday: JPMorgan (JPM US) is set to post the fastest earnings-per-share growth among major US investment banks this reporting season, according to data compiled by Bloomberg. Net interest income likely jumped 27% in the period, offsetting declines in trading revenues and investment-banking fees. The bank could beat its full-year NII guidance, defying the impact of persistently higher interest rates, said Piper Sandler. JPMorgan’s third-quarter report is due pre-market.

Author: Gabriel Sanchez, Redd Brown, Rachel Phua and Ignacio Gonzalez

Tags conss blk us alltop northam pnc us dal us stktop jpm us bnk pep us cos cons business top wfc us fin dpz us industries c us wba us